Stock Events

Abbott Laboratories 

$103.95
2575
-$0.28-0.27% Friday 20:00

Statistics

Day High
104.37
Day Low
103.58
52W High
121.04
52W Low
88.8
Volume
4,407,657
Avg. Volume
5,396,266
Mkt Cap
180.83B
P/E Ratio
32.28
Dividend Yield
2.12%
Dividend
2.2

Upcoming

Dividends

2.12%Dividend Yield
10Y Growth
9.6%
5Y Growth
11.44%
3Y Growth
6.92%
1Y Growth
7.84%

Earnings

18JulConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Next
0.93
1.02
1.1
1.19
Expected EPS
1.106567
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap353.71B
Johnson & Johnson competes with Abbott in multiple segments including medical devices, diagnostics, and pharmaceuticals, making it a direct competitor across several of Abbott's business lines.
Medtronic
MDT
Mkt Cap109.27B
Medtronic competes with Abbott in the medical devices sector, particularly in cardiovascular and diabetes care products.
Thermo Fisher Scientific
TMO
Mkt Cap222.94B
Thermo Fisher Scientific competes with Abbott in the diagnostics and life sciences sector, offering a range of analytical instruments, reagents, and consumables.
Danaher
DHR
Mkt Cap194.64B
Danaher Corporation competes with Abbott in the diagnostics and life sciences industry, particularly through its subsidiary Cepheid, which offers molecular diagnostics solutions.
Boston Scientific
BSX
Mkt Cap111.19B
Boston Scientific competes with Abbott in the medical devices sector, especially in cardiovascular products.
Baxter International
BAX
Mkt Cap17.27B
Baxter International competes with Abbott in the medical devices and nutrition sectors, offering products for critical care, nutrition, renal care, and more.
Stryker
SYK
Mkt Cap127.82B
Stryker competes with Abbott in the medical devices sector, particularly in orthopedics, which indirectly competes with Abbott's offerings in other medical device categories.
Becton Dickinson
BDX
Mkt Cap66.12B
Becton, Dickinson and Company competes with Abbott in the medical technology sector, offering devices, laboratory equipment, and diagnostic products.
Resmed
RMD
Mkt Cap31.33B
ResMed competes with Abbott in the health sector by providing medical devices for sleep disorders and respiratory conditions, which complements Abbott's broader medical device portfolio.
Hologic
HOLX
Mkt Cap17.22B
Hologic competes with Abbott in the diagnostics sector, particularly in women's health, where both companies offer a range of diagnostic and medical imaging solutions.

Analyst Ratings

126.17$Average Price Target
The highest estimate is $140.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Health Technology
Medical Specialties
Manufacturing
Pharmaceutical Preparation Manufacturing
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Show more...
CEO
Employees
114000
Country
US
ISIN
US0028241000
WKN
000850103

Listings